Kevin Pojasek

Kevin Pojasek is a prominent figure in the biotechnology sector, serving as the Co-Founder and Director (formerly Executive Chair) at Catamaran Bio, a company he co-founded in March 2020 and is based in Boston, Massachusetts. He has a robust background in leadership roles within various biotech firms and venture capital.

Education

• BA in Molecular, Cellular, and Developmental Biology from the University of Colorado Boulder (1994-1997)
• PhD in Biological Engineering from the Massachusetts Institute of Technology (1998-2003)

Professional Experience

• President and CEO at Enara Bio since September 2018, where he leads initiatives in innovative cancer therapies.
• Venture Partner at SV Health Investors, also since September 2018, focusing on investment strategies within the biotech field.
• Previously, he was the Chief Strategy and Business Officer at Immunocore Ltd., where he played a significant role in corporate strategy and business development, including securing substantial funding from the Bill & Melinda Gates Foundation.
• He co-founded Quartet Medicine and served as its President and CEO, as well as holding key positions at other biotech companies like Annovation Biopharma and Kala Pharmaceuticals.

Pojasek's career reflects a strong commitment to advancing biomedical innovation through strategic leadership and investment in emerging technologies within the life sciences sector. His contributions have been instrumental in shaping the direction of several companies aimed at addressing critical healthcare challenges.